Does Treating Subclinical Hypothyroidism Improve Markers of Cardiovascular Risk?
Serotonergic Agents as an Alternative to Hormonal Therapy for the Treatment of Menopausal Vasomotor Symptoms
Dual Peroxisome Proliferator-Activated Receptor-α/γ Agonists
A Review of Non-Hormonal Options for the Relief of Menopausal Symptoms
A Comparison of the Cycle Control, Safety, and Efficacy Profile of a 21-Day Regimen of Ethinylestradiol 20μg and Drospirenone 3mg with a 21-Day Regimen of Ethinylestradiol 20μg and Desogestrel 150μg
Opinion and Evidence for Treatments in Endocrine Disorders